82 related articles for article (PubMed ID: 2306287)
1. The relative abilities of MPTP and MPP+ to compete with [3H]dopamine for the rat and marmoset striatal dopamine uptake site.
Barnes NM; Cheng CH; Costall B; Naylor RJ
Biochem Pharmacol; 1990 Feb; 39(4):809-11. PubMed ID: 2306287
[No Abstract] [Full Text] [Related]
2. High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location.
Del Zompo M; Piccardi MP; Ruiu S; Corsini GU; Vaccari A
Eur J Pharmacol; 1991 Sep; 202(2):293-4. PubMed ID: 1802748
[No Abstract] [Full Text] [Related]
3. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
[TBL] [Abstract][Full Text] [Related]
4. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
5. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
6. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
[TBL] [Abstract][Full Text] [Related]
7. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
Mitsumoto Y; Mori A
Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
9. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
Carr LA; Basham JK; York BK; Rowell PP
Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
12. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
13. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent.
Freyaldenhoven TE; Cadet JL; Ali SF
Brain Res; 1996 Oct; 735(2):232-8. PubMed ID: 8911661
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
Debler EA; Hashim A; Lajtha A; Sershen H
Life Sci; 1988; 42(25):2553-9. PubMed ID: 3260319
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices.
Kurstjens NP; Cantrill RC
Eur J Pharmacol; 1989 Oct; 169(1):147-52. PubMed ID: 2574687
[TBL] [Abstract][Full Text] [Related]
16. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
17. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Staal RG; Yang JM; Hait WN; Sonsalla PK
Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
[TBL] [Abstract][Full Text] [Related]
18. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
Johannessen JN
Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
[TBL] [Abstract][Full Text] [Related]
19. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
20. The effect of prenatal treatment with MPTP or MPP+ on the development of dopamine-mediated behaviors in rats.
Weissman EM; Norman AB; Calderon SF; Zubrycki EM; el-Etri MM; Shipley MT; Sanberg PR
Pharmacol Biochem Behav; 1989 Nov; 34(3):545-51. PubMed ID: 2623012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
